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Abstract
Background: Assessment of outcomes for spinal surgeries is challenging, and an ideal measurement that reflects all
aspects of importance for the patients does not exist. Oswestry Disability Index (ODI), EuroQol (EQ-5D) and Numeric
Rating Scales (NRS) for leg pain and for back pain are commonly used patients reported outcome measurements
(PROMs). Reporting the proportion of individuals with an outcome of clinical importance is recommended. Knowledge
of the ability of PROMs to identify clearly improved patients is essential. The purpose of this study was to search cut-off
criteria for PROMs that best reflect an improvement considered by the patients to be of clinical importance.
Methods: The Global Perceived Effect scale was utilized to evaluate a clinically important outcome 12months after
surgery. The cut-offs for the PROMs that most accurately distinguish those who reported ‘completely recovered’ or
‘much improved’ from those who reported ‘slightly improved’, unchanged’, ‘slightly worse’, ‘much worse’, or ‘worse
than ever’ were estimated. For each PROM, we evaluated three candidate response parameters: the (raw) follow-up
score, the (numerical) change score, and the percentage change score.
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Results: We analysed 3859 patients with Lumbar Spinal Stenosis [(LSS); mean age 66; female gender 50%] and 617
patients with Lumbar Degenerative Spondylolisthesis [(LDS); mean age 67; 72% female gender]. The accuracy of
identifying ‘completely recovered’ and ‘much better’ patients was generally high, but lower for EQ-5D than for the
other PROMs. For all PROMs the accuracy was lower for the change score than for the follow-up score and the
percentage change score, especially among patients with low and high PROM scores at baseline.
The optimal threshold for a clinically important outcome was ≤24 for ODI, ≥0.69 for EQ-5D, ≤3 for NRS leg pain, and≤
4 for NRS back pain, and, for the percentage change score, ≥30% for ODI, ≥40% for NRS leg pain, and≥ 33% for NRS
back pain. The estimated cut-offs were similar for LSS and for LDS.
Conclusion: For estimating a ‘success’ rate assessed by a PROM, we recommend using the follow-up score or the
percentage change score. These scores reflected a clinically important outcome better than the change score.
Keywords: Lumbar spinal stenosis (LSS), Lumbar degenerative spondylolisthesis (LDS), Patient reported outcome
measures (PROMs), Oswestry disability index (ODI), Leg pain, Back pain, Success criteria, Minimal clinically important
difference (MCID)
Background
The success of surgical treatment of spinal degenerative
disorders is basically determined by reduction of pain and
improvement of function. In clinical studies, treatment
effects are most commonly assessed by patient reported
outcome measures (PROMs) [1–5]. Widely used PROMs
for evaluating outcomes after surgery for lumbar spinal
stenosis (LSS) with and without degenerative spondylolis-
thesis (LDS) are the Oswestry Disability Index (ODI) [1, 2,
4, 5], the numeric rating scales (NRS) for leg- and back pain
[1, 6–9], and a generic measure of health-related quality of
life such as the EQ-5D [8–10]. However, these outcome
measures do not necessarily cover all areas of interest to
the patient. Even though items like personal care and walk-
ing distance are addressed by the ODI, more specific dis-
abilities such as problems with personal hygiene, posture
imbalance and slow walking speed may not be detected.
Due to the frequent use of PROMS, the statistical ap-
plication and the interpretation of the clinical import-
ance of the outcomes should be evaluated [11]. The
clinical effect of a treatment is usually only presented as
the mean change from baseline to follow-up [1, 4, 5].
However, a statistically significant mean group difference
does not necessarily provide meaningful clinical infor-
mation when comparing two methods. A large improve-
ment in a few individuals in one of the treatment groups
can dramatically enhance the mean change of the group,
even if the majority had no improvement or even a slight
worsening of their complaints [11, 12]. Rather than discuss-
ing the relevance of mean changes alone, the proportion of
individuals with a clinically relevant reduction in pain and
disability (i.e., a ‘success’ rate) can be employed as a compre-
hendible metric for patients and physicians to use in clinical
decision-making [11–13].
To calculate ‘success’ rates assessed by PROMs, we
need criteria that reflect the patients’ perceptions of
important benefits following operations [11–13]. The
Minimal clinical important difference (MCID) was the
first metric developed for this purpose [14, 15]. Minimal
important changes (MIC) [16], a substantial clinical
benefit [17] and a satisfactory symptom state [18, 19] are
other metrics developed to distinguish whether patients
have achieved a clinically important effect of treatment
or not. Several authors have pointed out the great variabi-
lity and diversity of such thresholds [12, 20, 21], which may
be caused by the heterogeneity in the populations studied
[22]. The objective of the present study was to estimate the
thresholds for ODI, EQ-5D and NRS leg- and back pain
that best identify the patients who perceived a clinically
important outcome following surgery for LSS and LDS. Re-
ceiver Operating Characteristic (ROC) analyses were evalu-
ated to explore how accurately ‘success’ assessed by a single
question on the Global Perceived Effect (GPE) scale [23]
would be reflected in the PROMs. Despite limited evidence
for the validity of the GPE scale [12, 24], it is widely used
[17, 18, 25–28] and recommended [12, 29] in such analyses.
For each PROM three alternative response parameters were
evaluated: the follow-up score, the change score and the




Data were obtained from the Norwegian Registry for
Spine Surgery (NORSpine). NORSpine is a government-
funded, comprehensive, clinical registry for quality con-
trol and research. The registry receives no funding from
the industry. Informed consent is obtained from all pa-
tients. The patient form consists of PROMs completed
before surgery (baseline) and at 3- and 12-month
follow-up. During the hospital stay, data concerning
diagnosis, treatment and comorbidity were recorded by
the surgeons on a standard form.
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Inclusion criteria: (1) Patients registered in NORSpine
in the period 2007–2013; (2) Patients assessed by the
surgeon to have spinal stenosis with or without degen-
erative spondylolisthesis; (3) Patients operated with a de-
compression procedure or with decompression in
combination with posterior fusion. Patients with a
former operation at index level were excluded.
Patient reported outcome measures (PROMs)
1. The Oswestry Disability Index (ODI) V.2.0 [30, 31]
has been translated and validated for application
among Norwegian patients [32]. It is found to be an
appropriate instrument for assessing treatment
outcome in patients with spinal stenosis with and
without a degenerative spondylolisthesis [33]. It is a
self-reported instrument comprising 10 questions
about pain related disability in activities of daily life.
The sum score ranges from 0 (no disability) to 100
points (bedridden).
2. The EuroQol (EQ-5D) [34] is a generic
measurement for assessing health-related quality of
life. It evaluates mobility, self-care, usual activity,
pain/discomfort and anxiety/discomfort. For each
component the patients can choose between three
answers; none, mild to moderate, and severe. This
gives 35 = 243 possible sets of answers, and each
unique combination corresponds to a value between
− 0.59 and 1.0, where 1.0 represents perfect health.
3. Numeric Rating Scale (NRS) for back- and leg pain
assesses self-reported pain level in the last week
ranging from 0 (no pain) to 10 (worst conceivable
pain) [30].
4. Global Perceived Effect (GPE) is a single question
measuring patient-rated assessment of treatment
outcome [23]. The patient may choose between
seven response alternatives: ‘completely recovered’,
‘much improved’, ‘slightly improved’, unchanged’,
‘slightly worse’, ‘much worse’, and ‘worse than ever’.
Definition of ‘success’ according to GPE scale
Patients who rated themselves as ‘completely recovered’
or ‘much improved’ on the GPE scale (the anchor) at
12-month follow-up were considered to have gained a
clinically important outcome following the surgery (‘suc-
cess’), whereas patients that replied ‘slightly improved’,
unchanged’, ‘slightly worse’, ‘much worse’, and ‘worse than
ever’ were considered to have not benefited from their
operation (‘non-success’) [12, 17, 18, 35].
Statistics
For each PROM three alternative response parameters
were evaluated: 1) the (raw) follow-up score; 2) the (nu-
merical) change score (i.e., the absolute change from
baseline to follow-up); 3) the percentage change score
(i.e., the change score as a percentage of the baseline
score). In order to evaluate whether ‘success’ on the GPE
scale (the anchor) would be reflected in a PROM, Re-
ceiver Operating Characteristics (ROC) [36] curve ana-
lyses were performed. Analogue to a diagnostic test, the
sensitivity refers to the probability of detecting a condi-
tion. In the present setting it refers to the probability of
correctly classifying an individual replying ‘completely
recovered’ or ‘much improved’ (GPE) as a ‘success’ when
assessed by a PROM. Correspondingly, the specificity re-
fers to the probability of correctly classifying a patient
reporting less than ‘completely recovered’ or ‘much im-
proved’ as a ‘non-success’. Depending on the level of a
cut-off, the sensitivity and specificity will vary. A ROC
curve was made by plotting the sensitivity against 1
minus the specificity, for all possible cut-off values for
‘success’. The cut-off that maximized the proportion of
correctly classified patients according to the anchor was
chosen as the threshold for ‘success’. If more than one
cut-off value maximized the percentage of correct classi-
fication we prioritized the relation between sensitivity
and specificity that balanced the ratio between false neg-
atives and false positives [13, 36]. If possible, still with
the assumption of maximum correct classification and a
balanced false negatives/false positives ratio, we intended
to choose common cut-off values for LSS and LDS.
For all PROMs, the area under the ROC curves (AUC)
with 95% confidence interval (CI) was estimated for the
alternative response parameters. The AUC describes the
test’s accuracy in correctly classifying a case according to
the anchor – the larger the AUC, the greater the accur-
acy of the test. The AUC is classified as ‘excellent’ from
1.0 to 0.90, ‘good’ from 0.90 to 0.80, ‘fair’ from 0.80 to
0.70, ‘poor’ from 0.70 to 0.60, and ‘failed’ from 0.60 to
0.50 [37].
Since cut-off values for clinical improvement tend to
be dependent on the baseline level of a measurement
[26], a sensitivity analysis was performed. For each of
the estimated cut-off values the percentage of correct
classification was calculated for patient groups with low,
medium, and high baseline scores respectively. The split
values were chosen to ensure equal proportions of pa-
tients in each group (tertiary split). For ODI the split
values between groups were 32 and 46 points, for
EQ-5D they were 0.1 and 0.6. For NRS leg- and back
pain the low baseline group had scores of 1–5, the
medium baseline group, 6–7 and the high baseline
group, 8–10.
Baseline characteristics and PROMs were reported as
means and standard deviations of continuous variables
and as percentages of categorical variables. The mean
12-month follow-up scores and the mean changes from
baseline to follow-up were assessed against the
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categories of the GPE scale. To evaluate the predictive
validity of PROMs, correlations between the response on
the GPE scale and the PROMs were analysed using the
Spearman rank coefficient.
In a previous study from NORSpine, no differences in
outcome were found when comparing compliers and
non-compliers at follow-up [38]. We therefore assumed
that missing data were comparable to data from those
who answered, and performed the analysis based on the
listwise deletion method [39].
The statistical analyses were performed using the Stat-
istical Package for Social Sciences (SPSS) version 23.0
and by Stata version 14.0.
Results
Of 5238 eligible patients from 32 clinics, 4476 met the
inclusion criteria. Of these, 617 had a degenerative spon-
dylolisthesis. At 12-month follow-up, 3093 with LSS and
517 with LDS had answered the questionnaire, a
follow-up rate of 81% (Fig. 1).
The mean age (±SD) was 66 (±11) years for LSS and
67 (±10) years for LDS, and the percentage of females
was 50 and 72%, respectively. Further patient demo-
graphics and surgical data are presented in Table 1.
The mean (±SD) ODI changed from 40 (±15) at baseline
(Table 1) to 23 (±18) at 12-month follow-up (Table 2) for
LSS, and from 41 (±15) to 22 (±18) for LDS. Respectively
for LSS and LDS, EQ-5D changed from 0.37 (±0.32) to
0.64 and from 0.34 (±32) to 0.67, NRS leg pain from 6.6
(±2.2) to 3.5 (±3.0) and 6.7 (±2.2) to 3.2 (±2.9) and NRS
back pain from 6.4 (± 2.2) to 3.8 (±2.8) and 6.9 (±2.2) to
3.6 (±2.8). On the GPE-scale 58 and 65% replied that they
were ‘completely recovered’ or ‘much improved’ (LSS and
LDS, respectively). The Spearman rank coefficients
between the GPE ratings and the 12-month follow-up
measures were 0.77 and 0.78 for ODI, 0.73 and 0.78 for
EQ-5D, 0.72 and 0.68 for NRS leg pain and 0.76 and 0.78
for NRS back pain, respectively for LSS and LDS; p <
0.001 for all correlations (Table 2).
Figures 2, 3, 4 and 5 show the ROC curves for each of
the response parameters for ODI, EQ-5D and NRS leg-
and back pain. For all PROMs the graphs for the
follow-up scores and the percentage change scores illus-
trate larger areas under the curves (AUC) than for the
(numerical) change scores, indicating that the change
scores were less accurate in matching ‘successes’ from
the GPE scale.
In general, the computed AUC showed good or excel-
lent test accuracy (AUC from 0.82 to 0.92) for the three
alternative scores for all measurements except for the
EQ-5D’s change score [AUC = 0.76 (fair accuracy)].
However, for all PROMs, the AUC was generally lower
for the change scores than for the follow-up scores and
the percentage change scores, and in most cases this
Fig. 1 Flow chart for patients registered with spinal stenosis in NORSpine in the period 2007–2013
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difference was statistically significant (i.e., without over-
lap of the 95% CI (Table 3). For LSS, the AUC for ODI
was 0.90 (95% CI 0.89–0.91) for the follow-up score,
0.86 (95% CI 0.84–-0.87) for the numerical change score
and 0.91(95% CI 0.90–0.92) for the percentage change
score, and, respectively, 0.92 (95% CI 0.89–0.94), 0.86
(95% CI 0.82–0.89) and 0.92 (95% CI 0.90–0.94) for
LDS. The AUCs for all PROMs are listed in Table 3.
Except for the NRS back pain change score, the cut-off
values for a clinically important outcome were identical
for LSS and LDS (Table 3). The following cut-offs were
estimated, with the correct classification rates (for LSS
and LDS respectively) listed in parentheses:
ODI
follow-up score ≤ 24 points (82%, 85%), change score ≥ 13
points (78%, 80%), percentage change ≥30% (83%, 85%).
EQ-5D
follow-up score ≥ 0.692 points (78%, 84%), change score ≥
0.105 points (73%, 76%). Because the EQ-5D question-
naire values ranged from − 0.6 to 1.0 on a categorical
scale, it was not possible to find a mathematically ad-
equate method to evaluate the percentage change score.
NRS leg pain
follow-up score ≤ 3points (81%, 79%), change score ≥ 3
points (77%, 76%), percentage change ≥40% (81%, 78%).
NRS back pain
follow-up score ≤ 4 points (82%, 83%), change score ≥ 2
points for LSS (75%) and ≥ 3 points for LDS (79%), per-
centage change ≥33% (80%, 82%).
The sensitivity and specificity for each cut-off value
are listed in Table 4.
In the sensitivity analysis, a ≤ 24 point cut-off for the
ODI follow-up score gave 80% correctly classified pa-
tients in low, 85% in medium and 80% in high baseline
levels for LSS, respectively 87, 85 and 84% for LDS. The
corresponding rates for the ODI change score were 72,
84 and 78% for LSS, and 77, 86 and 75% for LDS, and,
for the percentage change score, 83, 85 and 80% for LSS,
and 88, 85 and 82% for LDS. Table 4 shows that also for
the other PROMs, the change scores for patients with
low and high baseline values were the least accurate in
matching ‘successes’ from the GPE scale.
Discussion
We evaluated how accurately four frequently used
PROMs would reflect the patients’ global assessment of
being completely recovered or much better at 12-month
follow-up. All outcome scores for the PROMs were
highly correlated to the GPE score, indicating good pre-
dictive validity. The accuracy for correct classification of
a GPE ‘success’ as a ‘success’ assessed by the PROMs was
generally high, however, lower for the (numerical)
change score than for the follow-up score and the per-
centage change score, especially among patients with
low and high preoperative PROM values. All estimated
Table 1 Patient demographics and surgical data for patients operated for spinal stenosis and for degenerative spondylolisthesis
Spinal stenosis Degenerative spondylolisthesis
N N
Age; Yr ± SD 3858 66 ± 11 617 67 ± 10
Female, no (%) 3859 1919 (50%) 617 444 (72%)
ASA level (1–4); Mean ± SD 3759 2.0 ± 0.6 608 2.0 ± 0.5
ASA level 1, no (%) 681 (18%) 82 (13%)
ASA level 2, no (%) 2349 (61%) 429 (71%)
ASA level 3, no (%) 753 (19%) 97 (16%)
ASA level 4, no (%) 12(0.3%) 0
Body Mass Index; Mean (SD) 3547 27 ± 4 560 27.0 ± 5
Smokers, no (%) 3808 877 (23%) 609 115 (19%)
Laminectomy, no (%) 3859 1024 (27%) 617 239 (39%)
Midline preserving decompression, no (%) 3859 2835 (73%) 617 378 (61%)
Fusion, no (%) 3859 214 (6%) 617 297 (48%)
ODI; Mean (SD) 3837 40 ± 15 617 41 ± 15
EQ-5D; Mean (SD) 3535 0.37 ± 0.32 564 0.34 ± 0.32
NRS leg pain; Mean (SD) 3559 6.6 ± 2.2 569 6.7 ± 2.2
NRS back pain; Mean (SD) 3597 6.4 ± 2.2 573 6.9 ± 2.1
N number of patient with data for the evaluated parameter
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Table 2 Follow-up scores and the change scores for PROMs according to the GPE-scale
Spinal stenosis Degenerative spondylolisthesis




















All 3060 23 (18) 0.77 * 16 (18) 0.66* 509 22 (18) 0.78* 19 (17) 0.64*
O Compl.recovered 599 (20%) 4 (9) 32 (16) 117 (23%) 4 (7) 33 (15)
D Much improved 1176 (38%) 17 (12) 21 (15) 213 (42%) 17 (13) 23 (14)
I Slightly
improved
658 (21%) 32 (12) 9 (13) 105 (21%) 36 (13) 9 (12)
Unchanged 283 (9%) 38 (13) 0 (10) 33 (6%) 38 (14) 5 (13)
Slightly worse 181 (6%) 42 (13) 0 (12) 21 (4%) 41 (13) 3 (13)
Much worse 117 (4%) 49 (12) −3 (12) 11 (2%) 51 (11) −8 (13)
Worse than ever 46 (2%) 59 (15) −11 (12) 9 (2%) 57 (17) −7 (15)
Missing 799 108
All 2464 0.64 (0.31) 0.73* 0.25 0.36 0.50* 419 0.67 (0.30) 0.78* 0.32 (0.34) 0.48*
E Compl.recovered 463 (19%) 0.92 (0.15) 0.47 (0.32) 97 (23%) 0.93 (0.16) 0.51 (0.30)
Q Much improved 945 (38%) 0.74 (0.17) 0.34 (0.32) 175 (42%) 0.75 (0.16) 0.37 (0.32)
- Slightly
improved
543 (22%) 0.55 (0.26) 0.19 (0.33) 89 (21%) 0.46 (0.29) 0.18 (0.31)
5 Unchanged 230 (9%) 0.41 (0.31) 0.03 (0.29) 26 (6%) 0.40 (0.30) 0.08 (0.33)
D Slightly worse 148 (6%) 0.33 (0.32) 0.00 (0.32) 17 (4%) 0.36 (0.30) 0.13 (0.29)
Much worse 100 (4%) 0.15 (0.23) 0.15 (0.32) 8 (2%) 0.30 (0.34) 0.02 (0.08)
Worse than ever 35 (1%) 0.04 (0.22) 0.24 (0.37) 7 (2%) 0.08 (0.24) 0.03 (0.11)
Missing 1395 198
L All 2988 3.5 (3.0) 0.72* 3.1 (3.3) 0.63* 493 3.2 (2.9) 0.68* 3.5 (3.2) 0.58*
E Compl.Recovered 580 19% 0.6 (1.5) 5.9 (2.5) 112 (23%) 0.6 (2.2) 6.0 (2.5)
G Much improved 1159 39% 2.5 (2.2) 4.0 (2.7) 208 (42%) 2.6 (2.2) 4.0 (2.7)
Slightly
improved
640 21% 4.9 (2.2) 1.8 (2.6) 102 (20%) 4.8 (2.4) 1.8 (2.6)
P Unchanged 275 9% 6.3 (2.1) 0.1 (2.3) 33 (7%) 6.1 (4.7) 0.4 (2.2)
A Slightly worse 176 6% 6.4 (2.1) 0.7 (2.6) 18 (4%) 5.2 (3.0) 1.0 (2.9)
I Much worse 114 4% 7.5 (2.1) −0.5 (2.6) 11 (2%) 6.6 (2.3) 0.4 (3.8)
N Worse than ever 44 1% 7.7 (2.1) −0.4 (2.9) 9 (2%) 7.8 (1.9) 0.0 (2.1)
Missing 871 124
B All 3033 3.8 (2.8) 0.76* 3.3 (2.9) 0.62* 507 3.6 (2.8) 0.78* 3.3 (2.9) 0.64*
A Compl.
recovered
592 20% 0.6 (1.4) 5.4 (2.5) 117 (23%) 0.7 (2.0) 5.8 (2.5)
C Much improved 1171 38% 3.0 (2.0) 3.2 (2.5) 214 (42%) 3.0 (2.0) 3.7 (2.5)
K Slightly
improved
648 21% 5.2 (1.9) 1.4 (2.3) 105 (21%) 5.7 (1.7) 1.6 (1.8)
Unchanged 278 9% 6.5 (2.0) 0.5 (2.0) 32 (6%) 6.0 (2.0) 1.4 (2.1)
P Slightly worse 182 6% 6.7 (1.8) 0.1 (2.0) 20 (4%) 6.7 (1.6) 0.3 (1.6)
A Much worse 116 4% 7.4 (2.1) −0.1 (2.2) 11 (2%) 7.3 (2.19 −0.2 (1.3)
I Worse than ever 46 2% 8.3 (1.9) −0.8 (2.3) 8 (2%) 8.5 (1.3) −0.4 (1.4)
N Missing 826 110
Mean 1 year follow-up scores and mean change scores from baseline to follow-up for ODI, EQ-5D, NRS leg pain, and NRS back pain [positive
values indicate decreased disability (ODI), improved health-related quality of life (EQ-5D), and reduced pain (NRS)]. Results are given for all
patients, and for patients stratified according to the Global Perceived Effect (GPE) scale. The association between the outcome measurements and
the GPE responses are given by Spearman’s rank correlation coefficients (Spearman’s rho)
*p<0.005
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cut-off values were the same for LSS and LDS, except
for the change score for NRS back pain.
Other studies
Follow-up score
In a study with a similar methodology to the present
study, Fekete et al. [18] suggested that a follow-up score
of ≤3 points is the best cut-off value for an acceptable
level of leg pain and back pain following surgery for
spinal stenosis with (n = 910) and without degenerative
spondylolisthesis (n = 1625). This is in accordance with
our estimate for leg pain and one point lower than our
estimate for back pain. In a study [19] on patients with
degenerative lumbar spine disorders operated with
decompression (n = 1288), the estimated cut-off for ODI
for a satisfactory symptom state was ≤22, nearly equiva-
lent to our own criterion (≤24). Furthermore, they found
the same cut-off estimates at 1-year and 2-year
follow-up [19].
Change score
Carreon et al. [40] analysed patients operated with pri-
mary fusion surgery – 332 for spinal stenosis with spondy-
lolisthesis (including both isthmic and degenerative cases)
and 153 for spinal stenosis without spondylolisthesis. They
evaluated the change score and found the minimum de-
tectable change (smallest change above the upper limit of
a 95% CI for the measurement error) to be 12.5 for ODI,
Fig. 2 Receiver Operating Characteristic curves for ODI. Legend: The closer the curve is in the upper left corner, the higher accuracy for
determining whether a patients is cured (‘completely recovered’ or ‘much improved’) or not. 2a. Spinal stenosis; 2b.
Degenerative spondylolisthesis
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1.2 for NRS leg pain and 1.1 for NRS back pain. All these
thresholds were below our estimated thresholds.
Glassman et al. [17] found 18.8 for ODI, 2.5 for
NRS leg pain and 2.5 for NRS back pain to be
cut-offs for a substantial clinical improvement for
patients (n = 357) treated with fusion surgery for sev-
eral spinal disorders. Their ODI limit was higher
than in our study, whereas their thresholds for pain
were in accordance with our results.
The use of change scores for benchmarking has been
criticized for not taking into account the patients’ base-
line scores [12, 18, 41]. A numerical change from high
baseline scores is probably of less importance than a
change from low baseline scores.
In the present study, the change scores’ weak ability to
correctly classify patients in the upper and lower base-
line groups lends support to this criticism.
Percentage change score
In order to account for the influence of the baseline
score on the outcome score, using the percentage
change score has been recommended [12, 42]. Based on
a literature review and an expert panel decision, Ostelo
et al. [42] concluded that a > 30% change from baseline
to follow-up was the best threshold for identifying clinic-
ally meaningful improvement in ODI and NRS back
pain. Their cut-off for ODI is identical to our estimate, and
their threshold for pain is in accordance with our estimate
Fig. 3 Receiver Operating Characteristic curves for EQ-5D. Legend: The closer the curve is in the upper left corner, the higher accuracy for determining
whether a patients is cured (‘completely recovered’ or ‘much improved’) or not. 3a. Spinal stenosis; 3b. Degenerative spondylolisthesis
Austevoll et al. BMC Musculoskeletal Disorders           (2019) 20:31 Page 8 of 15
(> 33%). Dworkin et al. [12] suggested a 30% reduction in
pain to be moderately important and a 50% reduction to be
substantially important for patients treated for chronic pain.
Our cut-off estimates for NRS leg- and back pain for LSS
and LDS were between these suggestions.
Methodical challenges
Because the EQ-5D questionnaire values ranged from −
0.59 to 1.0, it was not possible to adequately calculate
the percentage change score. Hence, only the 12-month
follow-up score and the change score could be provided
for the EQ-5D.
Application of the thresholds
As for other metrics developed for determining a clinically
relevant outcome following treatment (i.e., MCID [8],
(MIC) [27], a substantial clinical benefit [11] and a satisfac-
tory symptom state [28]), it is essential to recognize that
the thresholds from the present study cannot be directly
applied to comparisons of mean outcome scores between
groups [12, 13, 17, 43]. The thresholds are developed to de-
termine whether an individual has achieved an important
preoperative to postoperative benefit/improvement and
should be used in the same context when comparing
treatment effects [13]. Assuming a mean between-group
Fig. 4 Receiver Operating Characteristic curves for NRS leg pain. Legend: The closer the curve is in the upper left corner, the higher accuracy for
determining whether a patients is cured (‘completely recovered’ or ‘much improved’) or not. 4a. Spinal stenosis; 4b.
Degenerative spondylolisthesis
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difference in a PROM less than MCID to be clinically un-
important and a difference above MCID to be clinically im-
portant is warned against [12, 13, 43]. Instead the
proportion of patients reaching the threshold for
clinical improvement (the ‘success’ rate) should be
calculated for each treatment group. Then the ‘suc-
cess’ rates should be compared between the groups.
This approach is advocated as a statistically and
clinically useful tool for evaluating treatment effects
[12, 16, 17, 24, 43, 44]. In discussion with patients,
knowledge of the ‘success’ rate for a treatment can
be employed as clinically relevant information in a
shared decision-making process [17]. Furthermore,
knowing the difference in the ‘success’ rates of two
treatment groups makes it is possible to calculate
the number needed to treat to obtain one extra
patient with ‘success’ in an investigated group com-
pared to a control group (NNT = 100 divided by the
absolute difference in ‘success’ rate) [6, 12, 44]. For
example, in patients with degenerative spondylolis-
thesis treated with either decompression alone or de-
compression with fusion, assessed by ODI, how
many patients must be fused to get one more patient
with a clinically relevant outcome? [6]. Finally, as-
sumptions regarding the difference in the ‘success’
rate between groups provide the opportunity to esti-
mate a statistically and clinically relevant sample size
when planning a clinical trial [6, 12].
Fig. 5 Receiver Operating Characteristic curves for NRS back pain. Legend: The closer the curve is in the upper left corner, the higher accuracy for
determining whether a patients is cured (‘completely recovered’ or ‘much improved’) or not. 5a. Spinal stenosis; 5b.
Degenerative spondylolisthesis
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Table 4 Sensitivity and specificity for estimated cut-off values. Correct classification rate in different PROM baseline groups
Spinal stenosis Degenerative spondylolisthesis
Estimated cut-off Correct
classification
Sensitivity Specificity Estimated cut-off Correct
classification
Sensitivity Specificity
ODI follow-up score ≤24 0.83 0.80 ≤24 0.85 0.84
Low baseline 80% 87%
Medium 85% 85%
High baseline 80% 84%
ODI change score ≥13 0.78 0.77 ≥13 0.83 0.71
Low baseline 72% 77%
Medium 84% 86%
High baseline 78% 75%
ODI percentage change ≥30 0.87 0.77 ≥30 0.89 0.77
Low baseline 83% 88%
Medium 85% 85%
High baseline 80% 82%
EQ-5D follow-up score ≥0.692 0.76 0.81 ≥0.692 0.80 0.88
Low baseline 75% 81%
Medium 79% 80%
High baseline 80% 82%
EQ-5D change score ≥0.105 0.77 0.68 ≥0.105 0.81 0.63
Low baseline 73% 74%
Medium 75% 80%
High baseline 72% 71%
Leg pain follow-up score ≤3 0.80 0.83 ≤3 0.79 0.78
Low baseline 82% 81%
Medium 82% 76%
High baseline 81% 79%
Leg pain change score ≥3 0.78 0.75 ≥3 0.78 0.72
Low baseline 69% 70%
Medium 82% 76%
High baseline 78% 80%
Leg pain percentage change ≥40 0.82 0.80 ≥40 0.80 0.73
Low baseline 79% 75%
Medium 81% 76%
High baseline 81% 81%
Back pain follow-up score ≤4 0.84 0.79 ≤4 0.85 0.79
Low baseline 81% 82%
Medium 83% 80%
High baseline 82% 87%
Back pain change score ≥2 0.82 0.66 ≥3 0.78 0.80
Low baseline 72% 67%
Medium 83% 81%
High baseline 71% 83%
Back pain percentage change ≥33% 0.81 0.79 ≥33% 0.83 0.78
Low baseline 76% 78%
Medium 83% 80%
High baseline 80% 85%
The sensitivity describes the probability of correctly classifying an individual replying ‘completely recovered’ or ‘much improved’ (GPE) as a ‘success’ when assessed by the
estimated cut-offs for the PROMs. The specificity describes the probability for detecting a ‘non-success’ patient (one with a lower response at the GPE scale)
For each estimated cut-off values the percentage of correctly classified patients (correct classification) into ‘success’ and ‘non-success’ according to the anchor are given
separately for patients with low (ODI; 0–32, EQ-5D; −0.59-0.1, NRS leg and back pain; 0–5), medium (ODI; 32–46, EQ-5D; 0.1–0.6, NRS leg and back pain; 6–7), and high (ODI;
46 to 100, EQ-5D; 0.6–1.0, NRS leg and back pain; 8–10) baseline scores
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The proposed threshold from the present study is de-
rived from populations with LSS and LDS. The thresh-
old is condition-specific [13] and should be applied
solely to these conditions.
Strengths and limitations of the study
Strengths of this study are the large sample size and the
collection of data through a comprehensive and
well-structured registry. More than 90% of the national
centres performing spinal stenosis surgery report to the
registry, and currently more than 65% of operations for
spinal stenosis are registered. The follow-up rate was
good and in accordance with recommendations for spine
registries [45].
For research on effectiveness and efficacy following
treatment in a specific patient group it is recommended
to use criteria for clinical improvement derived from
populations similar to the one being studied [13]. The
estimated thresholds derived from patients operated for
LSS and LDS ensure reliable estimates for these condi-
tions. Finally, we consider the evaluation of all scores in
the same study and the consecutive sub-group analysis
of the three baseline groups to be strengths.
There are several major limitations in the method used
for determining the thresholds. As long as we know, the
validity of a single-item rating (GPE scale) of how the
patients are doing one year after spine surgery is not
proven specifically for LSS and LDS. However there are
some arguments in its favour. Using global assessment
to evaluate patients’ satisfaction with treatment outcome
in spinal disorders is recommended by international
panels of experts in the field [12, 46, 47]. The global as-
sessment of ‘pain free or much better’ and ‘much or very
much improved’ has been considered to be an appropri-
ate reference criterion for a successful outcome follow-
ing spinal surgery [35]. In a Norwegian study of the
validity of the GPE scale, the GPE replies were strongly
associated with the follow-up scores for PROMs [48].
Another limitation is the evaluation of self-report mea-
surements (ODI, EQ-5D, and NRS leg- and back pain)
against another related self-report instrument (GPE) as a
criterion [20]. Alternatively, an objective functional
‘non-self-report’ outcome, such as return to work, has
been recommended [20]. However, this criterion is also
criticized as return to work is not necessarily the pri-
mary goal for all patients, and it is not a relevant meas-
urement for an elderly patient group [49]. Walking
capacity is another criterion used to assess functional
outcome in patients with spinal stenosis. In addition to
asking about the walking distance before and after sur-
gery, an objective assessment of walking distance could
be recorded [50]. The differences in activity levels pre-
operatively and the patients expectations or anticipated
activity level after surgery should also be taken into
account. Patients’ who are happy to perform their lim-
ited activities of daily living, most probably accept more
disability than patients involved in more demanding ac-
tivities such as running and playing tennis. A suggested
method, the ‘benefit-harm trade-off method’ [51, 52], in
which the patients are asked to estimate how much
benefit they would consider sufficient to justify the risk
of getting worse after surgery, would take into account
the patients’ accepted physical performance level. For
the future this may be a suitable alternative approach for
determining ‘success’- criteria.
The method used in the present study is described in de-
tail and advocated by the ‘IMMPACT Recommendation’
[12], and is the most frequently used method for determin-
ing thresholds for clinical importance [17, 18, 25–28].
Furthermore, according to US FDA-recommended meth-
odology for defining thresholds for PROMs, the GPE scale
is considered a suitable anchor [29].
It is essential that the estimated PROM thresholds
should be utilised and interpreted with caution. The eva-
luated PROMs do not assess all aspects that may be con-
sidered important for an individual. A patient who obtains
an outcome in a PROM which exceeds the threshold for
clinical importance may have non-observed complaints
that are not detected; for example, loss of agility, slow
walking speed and general stiffness of the back. Further-
more, objective data such as measured walking distance
and muscle strength are not recorded in the registry ques-
tionnaire. Therefore, when reporting a ‘success’ rate it
should be made clear that it is only an estimate of the pro-
portion of patients reaching a threshold for improvement
in a PROM considered to be of importance for a patient.
An ideal PROM that covers all relevant domains of im-
portance for all kind of patients will give a more accurate
estimate of the ‘success’ rate.
Conclusion
For estimating ‘success’ rates assessed by PROMs for pa-
tients operated for LSS and LDS we recommend using
the follow-up score or the percentage change score.
These scores reflect a clinically important outcome more
accurately than the change score.
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